## Gene Summary
GRIK4, or glutamate ionotropic receptor kainate type subunit 4, is a protein-coding gene that belongs to the kainate family of glutamate receptors, which are neurotransmitter receptors highly important for synaptic transmission in the nervous system. These receptors respond to the neurotransmitter glutamate, which is the primary excitatory neurotransmitter in the central nervous system. GRIK4 encodes a subunit of a kainate glutamate receptor. Expression of GRIK4 is predominantly found in the brain, where it plays a critical role in modulating neurotransmission and synaptic plasticity.

## Gene Drugs, Diseases, Phenotypes, and Pathways
The role of GRIK4 has been studied in various neurological and psychiatric conditions, highlighting its significance in brain function and disease. It is particularly noted in the context of cognitive disorders and emotional regulation. GRIK4 has been implicated in major depressive disorder and has a potential linkage with schizophrenia. The gene's involvement in pathways related to glutamatergic signaling underpins its importance in synaptic transmission and potentially in neurogenesis. Given its role in brain functions, exploring GRIK4 can extend understanding of various neuropsychiatric conditions and cognitive processes.

## Pharmacogenetics
In pharmacogenetics, GRIK4 has attracted attention primarily in the context of treatment for psychiatric disorders. Specific variants of the GRIK4 gene have been associated with the therapeutic response to antidepressants in patients with depression. Notably, studies have indicated that certain polymorphisms in GRIK4 can predict the efficacy of citalopram, a commonly prescribed selective serotonin reuptake inhibitor (SSRI), suggesting that genetic screening might optimize treatment choices for individual patients. This denotes a significant step towards personalized medicine in the treatment of depressive disorders, potentially improving treatment outcomes by tailoring therapy based on genetic makeup.